Ignite Creation Date:
2024-05-05 @ 4:45 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00301379
Status:
TERMINATED
Last Update Posted:
2023-06-15
First Post:
2006-03-08
Brief Title:
Registry Study of Neoadjuvant Chemoradiation Transplant for Cholangiocarcinoma Patients
Sponsor:
Washington University School of Medicine
Organization:
Washington University School of Medicine
Study Overview
Official Title:
Prospective Registry Study of Neoadjuvant Therapy in Conjunction With Liver Transplantation for Cholangiocarcinoma
Status:
TERMINATED
Status Verified Date:
2023-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Low accrual
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is an observational study intended to validate results of a previous study done at the Mayo Clinic Patients are treated with combination chemotherapy and radiation and maintained on oral Xeloda until they can receive liver transplant A staging laparotomy is performed before chemoradiation in order to identify patients who will most benefit from the treatment and to improve outcomes
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None